Schinzel-Giedion Syndrome Overview
Learn About Schinzel-Giedion Syndrome
Schinzel-Giedion syndrome is a severe condition that is apparent at birth and affects many body systems. Signs and symptoms of this condition include distinctive facial features, neurological problems, and organ and bone abnormalities. Because of their serious health problems, most affected individuals do not survive past childhood.
Schinzel-Giedion syndrome is caused by mutations in the SETBP1 gene. This gene provides instructions for making a protein that attaches (binds) to certain regions of DNA to increase gene activity (expression). The SETBP1 protein is found throughout the body, but protein levels are highest during brain development before birth. During this time, nerve cells grow and divide (proliferate) and move (migrate) to their proper location in the brain. The SETBP1 protein is thought to control the activity of genes involved in these developmental processes.
Schinzel-Giedion syndrome is very rare, although the exact prevalence is unknown. At least 50 cases of the condition have been reported in the scientific literature.
Schinzel-Giedion syndrome results from new mutations in the SETBP1 gene and occurs in people with no history of the disorder in their family. One copy of the altered gene in each cell is sufficient to cause the disorder.
Rocco Piazza practices in Monza, Italy. Mr. Piazza is rated as an Elite expert by MediFind in the treatment of Schinzel-Giedion Syndrome. His top areas of expertise are Schinzel-Giedion Syndrome, Anaplastic Large Cell Lymphoma, Chronic Myelogenous Leukemia (CML), Trichorhinophalangeal Syndrome Type 1 (TRPS1), and Bone Marrow Transplant.
Andrew Chase practices in Southampton, United Kingdom. Mr. Chase is rated as a Distinguished expert by MediFind in the treatment of Schinzel-Giedion Syndrome. His top areas of expertise are Schinzel-Giedion Syndrome, Trichorhinophalangeal Syndrome Type 1 (TRPS1), Philadelphia-Negative Chronic Myeloid Leukemia, and Chronic Myelogenous Leukemia (CML).
William Tapper practices in Southampton, United Kingdom. Mr. Tapper is rated as a Distinguished expert by MediFind in the treatment of Schinzel-Giedion Syndrome. His top areas of expertise are Schinzel-Giedion Syndrome, Trichorhinophalangeal Syndrome Type 1 (TRPS1), Breast Cancer, Philadelphia-Negative Chronic Myeloid Leukemia, and Mastectomy.
Published Date: August 01, 2019
Published By: National Institutes of Health